ATE382341T1 - Nekrose-avides tracer-agent - Google Patents
Nekrose-avides tracer-agentInfo
- Publication number
- ATE382341T1 ATE382341T1 AT04761468T AT04761468T ATE382341T1 AT E382341 T1 ATE382341 T1 AT E382341T1 AT 04761468 T AT04761468 T AT 04761468T AT 04761468 T AT04761468 T AT 04761468T AT E382341 T1 ATE382341 T1 AT E382341T1
- Authority
- AT
- Austria
- Prior art keywords
- opqra
- phenanthro
- perylene
- dione
- necrosis
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 230000017074 necrotic cell death Effects 0.000 title abstract 2
- 239000000700 radioactive tracer Substances 0.000 title 1
- 239000000463 material Substances 0.000 abstract 3
- -1 phenanthro[1,10,9,8-opqra]perylene-7,14-dione compound Chemical class 0.000 abstract 3
- LEEJQTWXRMXYIB-UHFFFAOYSA-N quinone 7 Chemical class C12=CC=CC(C3=O)=C2C2=C4C3=CC=CC4=C3C4=C2C2=C1C=CC=C2C(=O)C4=CC=C3 LEEJQTWXRMXYIB-UHFFFAOYSA-N 0.000 abstract 2
- 206010061216 Infarction Diseases 0.000 abstract 1
- 206010028851 Necrosis Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 abstract 1
- 229940005608 hypericin Drugs 0.000 abstract 1
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 abstract 1
- 239000012216 imaging agent Substances 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 238000002595 magnetic resonance imaging Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- KNETYIQDFBQQRY-ZIOFQCKGSA-N mono-[123i]iodohypericin Chemical compound C12C3=C4C5C(C6=O)C(O)=C([123I])C(O)=C5C(C(O)C=C5O)=C3C5C(=O)C2=C(O)C=C(C)C1C1C4C6=C(O)C=C1C KNETYIQDFBQQRY-ZIOFQCKGSA-N 0.000 abstract 1
- 230000001338 necrotic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0317467.9A GB0317467D0 (en) | 2003-07-25 | 2003-07-25 | Tissue infraction and necrosis specific compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382341T1 true ATE382341T1 (de) | 2008-01-15 |
Family
ID=27772702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04761468T ATE382341T1 (de) | 2003-07-25 | 2004-07-23 | Nekrose-avides tracer-agent |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20070122340A1 (de) |
| EP (1) | EP1651201B1 (de) |
| AT (1) | ATE382341T1 (de) |
| DE (1) | DE602004011070T2 (de) |
| GB (1) | GB0317467D0 (de) |
| WO (1) | WO2005009423A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100048728A1 (en) * | 2006-08-03 | 2010-02-25 | Hy Biopharma Inc. | Polycyclic dianthraquinones as inhibitors of inflammatory cytokines |
| GB0723124D0 (en) * | 2007-11-26 | 2008-01-02 | Univ Leuven Kath | Targeted radiotherapy |
| US10286090B2 (en) | 2014-12-11 | 2019-05-14 | Rf Therapeutics Inc. | Targeted contrast agents comprising a hydrazide functional group |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898891A (en) * | 1987-08-07 | 1990-02-06 | Yeda Research And Development Company Ltd. | Antiviral compositions |
| US6013241A (en) * | 1995-01-23 | 2000-01-11 | Schering Aktiengesellschaft | Use of porphyrin-complex or expanded porphyrin-complex compounds as an infarction localization diagnosticum |
-
2003
- 2003-07-25 GB GBGB0317467.9A patent/GB0317467D0/en not_active Ceased
-
2004
- 2004-07-23 AT AT04761468T patent/ATE382341T1/de not_active IP Right Cessation
- 2004-07-23 WO PCT/BE2004/000107 patent/WO2005009423A1/en not_active Ceased
- 2004-07-23 EP EP04761468A patent/EP1651201B1/de not_active Expired - Lifetime
- 2004-07-23 US US10/595,062 patent/US20070122340A1/en not_active Abandoned
- 2004-07-23 DE DE602004011070T patent/DE602004011070T2/de not_active Expired - Lifetime
-
2009
- 2009-07-13 US US12/502,060 patent/US20090274622A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1651201B1 (de) | 2008-01-02 |
| EP1651201A1 (de) | 2006-05-03 |
| US20090274622A1 (en) | 2009-11-05 |
| DE602004011070D1 (en) | 2008-02-14 |
| DE602004011070T2 (de) | 2009-01-02 |
| US20070122340A1 (en) | 2007-05-31 |
| WO2005009423A1 (en) | 2005-02-03 |
| GB0317467D0 (en) | 2003-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2441668C2 (ru) | Новые визуализирующие агенты | |
| ES2525932T3 (es) | Derivados de dihidrotetrabenazina radiomarcados y su uso como agentes de imagenología | |
| ATE349446T1 (de) | Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel | |
| DK0907379T3 (da) | Bioaktiveret diagnostisk billeddannelseskontrastmiddel | |
| BR112013015786A2 (pt) | composição de agente de formação de imagem, método de formação de imagem de pelo menos uma parte de um indivíduo, e, método para preparar uma composição de polipeptídeo conjugado com quelante | |
| CA2607940A1 (en) | Bir domain binding compounds | |
| TNSN01130A1 (fr) | Formulations a liberation prolongee pour des secretagogues d'hormone de croissance | |
| DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
| EA200101046A1 (ru) | Производные индигоидных бис-индолов | |
| BRPI0516408B8 (pt) | derivados de estilbeno e seu uso para ligação e formação de imagem de placas de amilóide | |
| SG152254A1 (en) | Contrast agents for myocardial perfusion imaging | |
| CR10842A (es) | Derivados de acetileno y su uso para la union a placas amiloides y su diagnostico por imagenes | |
| MA29775B1 (fr) | Derives de pyrazolone | |
| IT1317862B1 (it) | Coniugati di acidi biliari con chelati complessi di ioni metallici eloro uso. | |
| WO2005053752A3 (en) | Novel imaging agents comprising caspase-3 inhibitors | |
| EA200600528A1 (ru) | Способ получения водорастворимых дитерпенов и их применение | |
| ATE357928T1 (de) | Pharmazeutische zusammensetzung für thrombinpeptidderivaten | |
| ITMI20011708A0 (it) | Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m | |
| MA32275B1 (fr) | Preparations orales et injectables de composes de tetracycline | |
| DE60120962D1 (de) | Substituierte chalkone als arzneimitteln | |
| WO2001021218A3 (en) | Method for determining viability of a myocardial segment | |
| ATE382341T1 (de) | Nekrose-avides tracer-agent | |
| EA200301023A1 (ru) | Заместительная терапия эстрогенами | |
| ATE522230T1 (de) | Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit | |
| AR017851A1 (es) | Composicion farmaceutica que comprende un eter carboxialquilico y una estatina, primera composicion farmaceutica para el uso con una segunda composicionfarmaceutica para lograr un efecto hipolipidemico y controlar el riesgo cardiaco adverso en un mamifero y conjunto para lograr dichos efectos terape |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |